Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based ChemotherapyNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, pulmonary large cell neuroendocrine carcinoma, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaActive, not recruitingPhase 12026-04-24NCT06736418

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Abdera Therapeutics Inc.1

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Dana-Farber Cancer InstituteBostonUnited States626
Florida Cancer Specialists - SarasotaSarasotaUnited States19
Hoag Memorial Hospital PresbyterianNewport BeachUnited States66
Huntsman Cancer InstituteSalt Lake CityUnited States107
Mayo Clinic - JacksonvilleJacksonvilleUnited States25
Mayo Clinic - RochesterRochesterUnited States59
MD AndersonHoustonUnited States56
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Sylvester Comprehensive Cancer Center, Univ of MiamiMiamiUnited States1
United TheranosticsGlen BurnieUnited States9
University of California, Los AngelesSanta MonicaUnited States3
University of California, San FranciscoSan FranciscoUnited States294